))
“People Are Claiming That Radiation Is Dead”: Esophagus Cancer at ASCO24 With Krish and Nina
Manage episode 426016351 series 3334771
Sisällön tarjoaa The Accelerators. The Accelerators tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
The Accelerators (Drs. Matt Spraker and Simul Parikh) host Radiation Oncologists and elite GI educators Drs. Krish Jethwa and Nina Sanford.
We discuss the exciting phase III ESOPEC study presented at ASCO 2024. The study demonstrated an overall survival benefit for perioperative FLOT chemotherapy versus pre-operative chemoradiation therapy for GE junction adenocarcinoma.
- Krish's ESOPEC thread on X
- Nina's ESOPEC thread on X
- Krish on TAP discussing esophageal radiotherapy dosing
- ASCO Daily News on the ESOPEC Study
- The FLOT4 Study
- Keynote-585 Study
- Latest publication from the DANTE trial
- MATTERHORN Trial at ESMO 2023
- ASCO Daily News on Keynote-585 and MATTERHORN (2024)
- The CheckMate 577 Study
- CALGB 80803 (Alliance) Study
- "The Firefighter Study from the 70s" (1981)
The Accelerators Podcast is a production of Photon Media, a division of the Cold Light Legacy Company.
If you'd like to support our efforts, please visit the Cold Light Legacy Company to learn more.
84 jaksoa
Jaa
